Published in J Mol Cell Cardiol on February 01, 1989
Platelet-activating factor: receptors and signal transduction. Biochem J (1993) 2.12
Structure and functions of classical cadherins. Biochemistry (Mosc) (2001) 1.40
Stretch affects phenotype and proliferation of vascular smooth muscle cells. Mol Cell Biochem (1995) 1.21
Morphological alterations in endothelial cells from human aorta and umbilical vein induced by forskolin and phorbol 12-myristate 13-acetate: a synergistic action of adenylate cyclase and protein kinase C activators. Proc Natl Acad Sci U S A (1986) 1.17
Guanine nucleotide-dependent, pertussis toxin-insensitive regulation of phosphoinositide turnover by bradykinin in bovine pulmonary artery endothelial cells. FASEB J (1989) 1.04
Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 3. Inhibitory effect of SkQ1 on tumor development from p53-deficient cells. Biochemistry (Mosc) (2008) 1.04
T-cadherin and signal-transducing molecules co-localize in caveolin-rich membrane domains of vascular smooth muscle cells. FEBS Lett (1998) 1.03
Urokinase as a multidomain protein and polyfunctional cell regulator. Biochemistry (Mosc) (2002) 1.01
Influence of vasoactive agents on cytoplasmic free calcium in vascular endothelial cells. J Appl Physiol (1985) (1988) 0.97
Plasminogen activators in vascular remodeling and angiogenesis. Biochemistry (Mosc) (2002) 0.93
Ca2+-dependent interaction of 5-dimethylaminonaphthalene-1-sulfonyl-calmodulin with cyclic nucleotide phosphodiesterase, calcineurin, and troponin I. J Biol Chem (1982) 0.92
Density- and proliferation status-dependent expression of T-cadherin, a novel lipoprotein-binding glycoprotein: a function in negative regulation of smooth muscle cell growth? FEBS Lett (1998) 0.89
Platelet membrane calmodulin-stimulated calcium-adenosine triphosphatase. Altered activity in essential hypertension. Hypertension (1986) 0.87
LDL binds to surface-expressed human T-cadherin in transfected HEK293 cells and influences homophilic adhesive interactions. FEBS Lett (1999) 0.86
Chemotactic effect of urokinase plasminogen activator: a major role for mechanisms independent of its proteolytic or growth factor domains. J Recept Signal Transduct Res (1999) 0.86
Urokinase plasminogen activator enhances neointima growth and reduces lumen size in injured carotid arteries. J Hypertens (2000) 0.86
Endothelin-1 and endothelin-3 stimulate calcium mobilization by different mechanisms in vascular smooth muscle. Biochem Biophys Res Commun (1992) 0.86
Urokinase plasminogen activator induces human smooth muscle cell migration and proliferation via distinct receptor-dependent and proteolysis-dependent mechanisms. Mol Cell Biochem (1999) 0.86
Mesenchymal stem cells in tissue growth and repair. Acta Naturae (2011) 0.85
Ligand selectivity of 105 kDa and 130 kDa lipoprotein-binding proteins in vascular-smooth-muscle-cell membranes is unique. Biochem J (1996) 0.84
Involvement of Ni protein in the functional coupling of the atrial natriuretic factor (ANF) receptor to adenylate cyclase in rat lung plasma membranes. Eur J Biochem (1988) 0.84
Different electrical responses to vasoactive agonists in morphologically distinct smooth muscle cell types. Circ Res (1994) 0.84
[Mechanisms of Vascular Remodeling Following Arterial Injury]. Kardiologiia (2015) 0.83
Concerted effects of lipoproteins and angiotensin II on signal transduction processes in vascular smooth muscle cells. Arterioscler Thromb (1993) 0.83
Calmodulin activates adenylate cyclase from rabbit heart plasma membranes. FEBS Lett (1984) 0.83
Interaction of stable prostaglandin endoperoxide analogs U46619 and U44069 with human platelet membranes: coupling of receptors with high-affinity GTPase and adenylate cyclase. Thromb Res (1985) 0.83
Cardiovascular drugs and atherosclerosis: effects of calcium antagonists, beta-blockers, and nitrates on atherosclerotic characteristics of human aortic cells. J Cardiovasc Pharmacol (1988) 0.83
[Adipose stromal cells--plastic type of cells with high therapeutic potential]. Tsitologiia (2006) 0.81
Characteristics of low and high density lipoprotein binding and lipoprotein-induced signaling in quiescent human vascular smooth muscle cells. Mol Pharmacol (1994) 0.81
Cellular signalling by lipoproteins in cultured smooth muscle cells from spontaneously hypertensive rats. J Vasc Res (1993) 0.80
Increased pressure induces sustained protein kinase C-independent herbimycin A-sensitive activation of extracellular signal-related kinase 1/2 in the rabbit aorta in organ culture. Circ Res (1997) 0.80
Insulin resistance and adipogenesis: role of transcription and secreted factors. Biochemistry (Mosc) (2013) 0.80
T-cadherin activates Rac1 and Cdc42 and changes endothelial permeability. Biochemistry (Mosc) (2009) 0.80
Low- and high-density lipoproteins as hormonal regulators of platelet, vascular endothelial and smooth muscle cell interactions: relevance to hypertension. J Hypertens Suppl (1991) 0.80
Characterization of an atypical lipoprotein-binding protein in human aortic media membranes by ligand blotting. Biochem J (1994) 0.80
Heterotrimeric Gi protein is associated with the inositol 1,4,5-trisphosphate receptor complex and modulates calcium flux. Cell Calcium (1998) 0.80
[Role of guanyl nucleotides in regulation of activity of heart adenylate cyclase by chloride ions]. Biokhimiia (1981) 0.80
Oxidized low density lipoproteins stimulate phosphoinositide turnover in cultured vascular smooth muscle cells. Arterioscler Thromb (1992) 0.79
[Biochemical features of platelet alpha2-adrenergic receptors and their connection with an increase in concentration of intracellular Ca2+]. Biokhimiia (1989) 0.79
Urokinase induces ROS production in vascular smooth muscle cells. Bull Exp Biol Med (2006) 0.79
Vascular signal transduction and atherosclerosis. Ann N Y Acad Sci (1990) 0.79
Regulation of Immunity via Multipotent Mesenchymal Stromal Cells. Acta Naturae (2012) 0.79
Activation energy of skeletal muscle sarcolemmal Na+,K+-adenosine triphosphatase. Biochim Biophys Acta (1974) 0.78
[Adipose tissue stromal cells -- multipotent cells with therapeutic potential for stimulation of angiogenesis in tissue ischemia]. Kardiologiia (2006) 0.78
Low- and high-density lipoproteins as mitogenic factors for vascular smooth muscle cells: individual, additive and synergistic effects. J Vasc Res (1995) 0.78
[T-cadherin suppresses the cell proliferation of mouse melanoma B16F10 and tumor angiogenesis in the model of the chorioallantoic membrane]. Ontogenez (2010) 0.78
Stimulation of non-selective cation channels providing Ca2+ influx into platelets by platelet-activating factor and other aggregation inducers. Eur J Biochem (1991) 0.78
Calcium-dependent interaction of dansyl-calmodulin and phosphodiesterase: relationship to Ca2+ requirement for enzyme activation. Adv Cyclic Nucleotide Protein Phosphorylation Res (1984) 0.78
Blocking of the receptor-stimulated calcium entry into human platelets by verapamil and nicardipine. Thromb Res (1988) 0.77
Platelets in patients with homozygous familial hypercholesterolemia are sensitive to Ca(2+)-mobilizing activity of low density lipoproteins. Atherosclerosis (1992) 0.77
Abnormal cellular calcium regulation in essential hypertension. J Cardiovasc Pharmacol (1986) 0.77
Stimulation of high-affinity hormone-sensitive GTPase of human platelets by 1-O-alkyl-2-O-acetyl-sn-glyceryl-3-phosphocholine (platelet activating factor). Biochem Biophys Res Commun (1985) 0.77
[Effect of pH on Ca-binding properties of calmodulin and on its interaction with Ca-dependent phosphodiesterase of cyclic nucleotides]. Biokhimiia (1981) 0.77
Monocyte integrin expression and monocyte-platelet complex formation in humans with coronary restenosis. Clin Exp Pharmacol Physiol (2001) 0.77
[Therapeutic Angiogenesis Using Growth Factors: Current State and Prospects for Development]. Kardiologiia (2015) 0.77
Alterations in beta-adrenoceptor density on T-lymphocytes upon activation with interleukin-2 and phytohaemagglutinin. Biomed Sci (1990) 0.77
The regulatory effect of ATP and its non-hydrolyzed analogs on heart adenylate cyclase. Biochem Int (1983) 0.77
Interaction between kringle and growth-factor-like domains in the urokinase molecule: possible role in stimulation of chemotaxis. Biochemistry (Mosc) (2008) 0.77
Molecular modeling as a new approach to the development of urokinase inhibitors. Bull Exp Biol Med (2015) 0.77
Identification of 130 kDa cell surface LDL-binding protein from smooth muscle cells as a partially processed T-cadherin precursor. Biochim Biophys Acta (1999) 0.77
Epinephrine potentiates activation of human platelets by low density lipoproteins. Biochim Biophys Acta (1991) 0.77
[Phorbol ester blocks the coupling of GTP-binding protein with receptor-controlled calcium channels]. Biokhimiia (1989) 0.77
Urokinase plasminogen activator system in humans with stable coronary artery disease. Clin Exp Pharmacol Physiol (1999) 0.77
Relationship between the inhibition of receptor-induced increase in cytosolic free calcium concentration and the vasodilator effects of nitrates in patients with congestive heart failure. Int J Cardiol (1990) 0.76
[Mechanism of stimulation of angiogenesis in ischemic myocardium with the help of adipose tissue stromal cells]. Kardiologiia (2010) 0.76
LDL- and agonist-induced Ca(2+)-mobilization in platelets of healthy subjects and in patients with familial hyperlipoproteinemia type II. Thromb Res (1991) 0.76
Ca2+-agonistic effect of a T-type Ca-channel blocker mibefradil (Ro 40-5967). Membr Cell Biol (2000) 0.76
Characteristics of smooth muscle cell lipoprotein binding proteins (p105/p130) as T-cadherin and regulation by positive and negative growth regulators. Biochem Biophys Res Commun (1998) 0.76
[Genetic factors of risk of ischemic heart disease development in patients with familial hypercholesterolemia]. Kardiologiia (2005) 0.76
Decrease of platelet aggregation and spreading via inhibition of the cAMP phosphodiesterase by trapidil. FEBS Lett (1984) 0.76
Calmodulin and troponin C as targets for drug action. Biomed Biochim Acta (1987) 0.76
Blockade of receptor-operated calcium channels by mibefradil (Ro 40-5967): effects on intracellular calcium and platelet aggregation. Cardiovasc Drugs Ther (1995) 0.76
Evidence for the receptor-operated calcium channels in human platelet plasma membrane. Thromb Res (1987) 0.76
[UROKINASE SYSTEM INVOLVES IN VASCULAR CELLS MIGRATION AND REGULATES THE GROWTH AND BRANCHING OF CAPILLARIES]. Tsitologiia (2015) 0.76
Comparison of binding of 3H-desmethoxyverapamil and 3H-mibefradil in vascular smooth muscle and heart membranes. Possible binding of mibefradil to a site distinct from the phenylalkylamine-binding site. Arzneimittelforschung (1996) 0.76
Atherogenic effects of beta blockers on cells cultured from normal and atherosclerotic aorta. Am J Cardiol (1988) 0.76
Platelet calcium-linked abnormalities in essential hypertension. Ann N Y Acad Sci (1986) 0.76
[Hypoxia as the main activator of angiogenesis and fatty tissue growth]. Ross Fiziol Zh Im I M Sechenova (2009) 0.75
[Molecular mechanisms of gradient sensing in mesenchymal cells]. Ross Fiziol Zh Im I M Sechenova (2013) 0.75
[Fast and highly-sensitive method of quantitative determination of carnosine and anserine in animal tissues]. Vopr Med Khim (1977) 0.75
[Calcium-dependent regulation of cardiac adenyl cyclase by calmodulin]. Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR (1984) 0.75
Regulation of adenylate cyclase by hormones and guanine nucleotides in normal, desensitized, and resensitized rabbit heart. Adv Myocardiol (1982) 0.75
[Effect of lipids on the binding of calmodulin with cyclic nucleotide phosphodiesterase]. Biokhimiia (1983) 0.75
[Economic reform is the road to increasing the efficiency of pharmacy administration]. Farm Zh (1973) 0.75
[Pathomorphosis of lung cancer following preoperative intensive split radiation]. Vrach Delo (1976) 0.75
[Effect of fatty acids on calmodulin regulation of adenylate cyclase from the brain striatal system]. Biokhimiia (1983) 0.75
[Status and tasks of the drug control service in the Ukraine]. Farm Zh (1974) 0.75
[Lateral thoracotomy without complete muscle dissection]. Klin Khir (1976) 0.75
Guanine-nucleotide-dependent inhibition of adenylate cyclase of rabbit heart by glucagon. Eur J Biochem (1984) 0.75
[Inhibition of cyclic nucleotide phosphodiesterase from rabbit heart by hydroxypyridines]. Vopr Med Khim (1983) 0.75
[Drug supply of therapeutic institutions in the Ukraine during 1962-1972]. Sov Zdravookhr (1974) 0.75
Characterization of two forms of cyclic nucelotide phosphodiesterase from rabbit heart. Adv Myocardiol (1982) 0.75
[Tasks of pharmacy workers of the Republic in fulfilling the socialist obligations of the 2d year of the 10th Five-Year Plan]. Farm Zh (1977) 0.75
[The molecular basis for active transport of univalent cations]. Usp Sovrem Biol (1976) 0.75
[Participation of calmodulin and the guanine nucleotide-binding regulator component in regulating cardiac adenylate cyclase]. Dokl Akad Nauk SSSR (1984) 0.75